Amgen bets on ChemoCentryx’s rare disease drug in $3.7 billion deal
Amgen has been facing stiff competition for its top-selling arthritis drug, Enbrel, from newer branded treatments and patents for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alexion Pharma
M&As in bio/pharma industry high despite COVID-19: GlobalData
Down only 13 per cent compared with last year, with a total deal value of $228 billion compared with $262 billion in 2020, and…